Former CEO of Spirit Airlines, Co-Inventor of Lipitor, A Top Selling Drug Of All Time, Join CrossWork Board of Advisors.

The former CEO of Spirit Airlines, Ben Baldanza, and a co-inventor of Lipitor, Charles Bisgaier, have recently joined CrossWork’s pre-IPO advisory board. During Mr. Baladanza’s tenure at Spirit, Spirit completed…

Continue ReadingFormer CEO of Spirit Airlines, Co-Inventor of Lipitor, A Top Selling Drug Of All Time, Join CrossWork Board of Advisors.

The number of pre-IPO companies worth $1 billion or more (“unicorns”) has doubled (approximately) over last year to now over 1,000 companies.

At CrossWork.us, we expect the number of pre-IPO unicorns to continue to rise as the pace and quality of entrepreneurial innovation continues to accelerate and an increased amount of equity…

Continue ReadingThe number of pre-IPO companies worth $1 billion or more (“unicorns”) has doubled (approximately) over last year to now over 1,000 companies.